Beqvez, a discontinued gene therapy for hemophilia B, reduces joint bleeding in patients, new data from Phase 3 clinical ...
Today, we're seeing more women with hemophilia diagnosed earlier, but there's still work to do, says columnist.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback